Author(s)

Fatima-Ezzahra Tahiri^1*, Karima El Fakiri¹, Nourredine Rada¹, Ghizlaine Draiss¹, Nadia El Idrissi Slitine², Mounir Bourrous³, Said Younous³, Mohammed Bouskraoui⁴

¹Pediatrics Department A, University Hospital Center Mohamed VI, Marrakech, Morocco.
²Department of Neonatal Resuscitation, University Hospital Center Mohamed VI, Marrakech, Morocco.
³Pediatric Emergency Department, University Hospital Center Mohamed VI, Marrakech, Morocco.
⁴Pediatric Intensive Care Unit, University Hospital Center Mohamed VI, Marrakech, Morocco.

Pediatric inflammatory multisystem syndrome PIMS is a new entity of systemic inflammatory disease in children that appeared in the epidemic context of COVID-19 infection in April 2020. The pathophysiological mechanisms of PIMS are poorly understood and the hypothesis of a maladaptive hyperactive immune response, notably involving cytokines, is described in the literature. In our study, we report our experience regarding the clinical presentation, diagnosis, management and outcome of patients who presented with pediatric inflammatory multisystem syndrome post COVID-19.

COVID-19, Inflammation, Kawasaki Like, Myocarditis, Immunoglobulins

Tahiri, F. , Fakiri, K. , Rada, N. , Draiss, G. , Slitine, N. , Bourrous, M. , Younous, S. and Bouskraoui, M. (2023) Pediatric Inflammatory Multisystem Syndrome; Unusual Presentation of COVID-19 in Children: About Thirty Cases. Open Journal of Pediatrics, 13, 74-81. doi: 10.4236/ojped.2023.131009.